Clinical trial
WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for…
NCT00349674 · Hospices Civils de Lyon, Other · Unknown status
Key facts
| NCT number | NCT00349674 |
|---|---|
| Title | WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides |
| Official title | Treatment of ANCA-Associated Vasculitides : Corticosteroids and Pulse Cyclophosphamide Followed by Maintenance Therapy With Methotrexate or Azathioprine: a Prospective Multicenter Randomized Trial |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Wegener's Granulomatosis |
| Intervention type | Drug |
| Interventions | Azathioprine: 2 mg/kg/day, methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week |
| Enrollment | 126 |
| Start date | Jan 1, 1999 |
| First posted | Jul 7, 2006 |
| Last update posted | Oct 10, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: